N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an α7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate

被引:15
|
作者
Zanaletti, Riccardo [1 ]
Bettinetti, Laura [1 ]
Castaldo, Cristiana [1 ]
Ceccarelli, Ilaria [1 ]
Cocconcelli, Giuseppe [1 ]
Comery, Thomas A. [2 ]
Dunlop, John [2 ]
Genesio, Eva [1 ]
Ghiron, Chiara [1 ]
Haydar, Simon N. [2 ]
Jow, Flora [2 ]
Maccari, Laura [1 ]
Micco, Iolanda [1 ]
Nencini, Arianna [1 ]
Fratelli, Carmela [1 ]
Scali, Carla [1 ]
Turlizzi, Elisa [1 ]
Valacchi, Michela [1 ]
机构
[1] Siena Biotech SpA, I-53100 Siena, Italy
[2] Pfizer Inc, Neurosci Res Unit, Groton, CT 06340 USA
关键词
DISCOVERY; SCHIZOPHRENIA; RAT;
D O I
10.1021/jm3013568
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
alpha 7 nicotinic acetylcholine receptors (alpha 7 nAChR) represent promising therapeutic candidates for the treatment of cognitive impairment, associated with Alzheimer's disease (AD) and schizophrenia. A medicinal chemistry effort around previously reported compound 1 (SEN15924, WAY 361789) led to the identification of 12 (SEN78702, WYE-308775) a potent and selective full agonist of the alpha 7 nAChR that demonstrated improved plasma stability, brain levels, and efficacy in behavioral cognition models.
引用
收藏
页码:10277 / 10281
页数:5
相关论文
共 50 条
  • [1] 1-{[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl]carbonyl]}piperidin-4-one
    Shahani, Tara
    Fun, Hoong-Kun
    Ragavan, R. Venkat
    Vijayakumar, V.
    Venkatesh, M.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O3233 - U1225
  • [2] Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789)
    Zanaletti, Riccardo
    Bettinetti, Laura
    Castaldo, Cristiana
    Cocconcelli, Giuseppe
    Comery, Thomas
    Dunlop, John
    Gaviraghi, Giovanni
    Ghiron, Chiara
    Haydar, Simon N.
    Jow, Flora
    Maccari, Laura
    Micco, Iolanda
    Nencini, Arianna
    Scali, Carla
    Turlizzi, Elisa
    Valacchit, Michela
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) : 4806 - 4823
  • [3] N-(6-Chloro-3-nitropyridin-2-yl)-5-(1-methyl-1H-pyrazol-4- yl)isoquinolin-3-amine
    Wydra, Valentin
    Gerstenecker, Stefan
    Schollmeyer, Dieter
    Andreev, Stanislav
    Dimitrov, Teodor
    Massarico Serafim, Ricardo Augusto
    Laufer, Stefan
    Gehringer, Matthias
    MOLBANK, 2021, 2021 (01) : 1 - 6
  • [4] 4-{[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl]carbonyl}-N-(4-cyanophenyl)piperazine-1-carboxamide
    Loh, Wan-Sin
    Fun, Hoong-Kun
    Ragavan, R. Venkat
    Vijayakumar, V.
    Venkatesh, M.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O2563 - U481
  • [5] 4-{[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl]carbonyl}-N-ethylpiperazine-1-carboxamide
    Shahani, Tara
    Fun, Hoong-Kun
    Vijayakumar, V.
    Ragavan, R. Venkat
    Sarveswari, S.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1747 - U1226
  • [6] Crystal structure of (E)-N-{[3-methyl-1pheny-l- 5-(1H-pyrrol-1-yl)-1H-pyrazol-4yl] methylidene} hydroxylamine
    Mague, Joel T.
    Mohamed, Shaaban K.
    Akkurt, Mehmet
    Ei-Emary, Talaat I.
    Albayati, Mustafa R.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : O - +
  • [7] 2-{5-[N-(4-tert-butylbenzyl)carbamoyl]-3-phenyl-1H-pyrazol-1-yl}acetic acid
    Ge, Yan-Qing
    Xia, Yong
    Dong, Wen-Liang
    Wei, Fang
    Zhao, Bao-Xiang
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : o1287 - o1288
  • [8] Synthesis and Biological Activities of Novel N-(2-(5-(3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-1,3,4-oxadiazol-2-yl)-4-chloro-6-methylphenyl) Amides
    Zhang, Yan
    Shang, Junfeng
    Li, Huan
    Liu, Hang
    Song, Haibin
    Wang, Baolei
    Li, Zhengming
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2020, 40 (03) : 787 - 793
  • [9] Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus
    Park, Kaapjoo
    Lee, Byoung Moon
    Hyun, Kwan Hoon
    Lee, Dong Hoon
    Choi, Hyun Ho
    Kim, Hyunmi
    Chong, Wonee
    Kim, Kyeong Bae
    Nam, Su Youn
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (07) : 2280 - 2293
  • [10] Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a Potential Peripheral Cannabinoid-1 Receptor Inverse Agonist
    Hung, Ming-Shiu
    Chang, Chun-Ping
    Li, Ting-Chieh
    Yeh, Teng-Kuang
    Song, Jen-Shin
    Lin, Yinchiu
    Wu, Chien-Huang
    Kuo, Po-Chu
    Amancha, Prashanth K.
    Wong, Ying-Chieh
    Hsiao, Wen-Chi
    Chao, Yu-Sheng
    Shia, Kak-Shan
    CHEMMEDCHEM, 2010, 5 (09) : 1439 - 1443